National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 15,818 cases where Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 18 out of 1,582

Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next


VAERS ID: 1000885 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-01-19
Onset:2021-01-26
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9261 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Deep vein thrombosis, Oedema peripheral, Peripheral swelling, Pulmonary embolism
SMQs:, Cardiac failure (broad), Angioedema (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: POTASSIUM CHLORIDE; HYDROCODONE-ACETAMINOPHEN; LISINOPRIL; NORCO; VICODIN; MAGNESIUM; IBUPROFEN; JARDIANCE; BASAGLAR KWIKPEN; METHOCARBAMOL; OMEPRAZOLE; METFORMIN; LOVASTATIN; FUROSEMIDE; AMLODIPINE; ALLOPURINOL
Current Illness: Posterior lumbar interbody fusion @L3-4(N/A spine lumbar) 1-7-21
Preexisting Conditions: LUMBAR SPINAL STENOSIS; BACK PAIN; CARPAL TUNNEL SYNDROME; DIABETES TYPE II; ERECTILE DYSFUNCTION; ESOPHAGEAL REFLUX; FAMILY HISTORY OF CAD; HYPERLIPIDEMIA; HYPERTENSION NOS; OBESITY; OBSTRUCTIVE SLEEP APNEA
Allergies: Metoprolol/Potassium Chloride Crys ER
Diagnostic Lab Data: See Attached.
CDC Split Type:

Write-up: 1-7-21 - Posterior lumbar interbody fusion @ L3-4 (N/A spine lumbar) by Dr. 1-19-21 - 1st dose Pfizer Covid-19 vaccine given. 1-26-21 - Swelling of (R) calf (H/O peripheral edema) 1-29-21 - 1-31-21 - Hospitalized with DVT (R.leg) & PE (lungs bilaterally)


VAERS ID: 1001120 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-01-12
Onset:2021-01-13
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Eyelid disorder, Lip disorder, Petechiae, Pharyngeal paraesthesia
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Periorbital and eyelid disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: peanuts, seafood, legumes, latex, avocado, jicama, sesame oil,
Diagnostic Lab Data:
CDC Split Type:

Write-up: droopy eye lids tiny bumps on upper and lower lips throat was tingling both hands petechia


VAERS ID: 1002107 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2021-01-27
Onset:2021-01-27
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Injection site inflammation, Superficial vein prominence, Ultrasound Doppler, Vasculitis
SMQs:, Extravasation events (injections, infusions and implants) (broad), Vasculitis (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Seroquel, Wellbutrin, lamotradine, Vitamin D, Iron, mtv, melatonin
Current Illness: no
Preexisting Conditions: Bipolar
Allergies: PCN''s
Diagnostic Lab Data: Vascular ultrasound completed with no abnormal findings noted
CDC Split Type:

Write-up: Profound inflammation of vascular structure originating at injection site and radiating out, vascular structure highly visible through skin. No treatment only observation. After 3 days vascular structures beginning to fade and return to baseline, however, veins are still highly visible and very pronounced.


VAERS ID: 1002522 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2021-01-14
Onset:2021-01-26
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Alanine aminotransferase increased, Anti-GAD antibody, Antibody test, Aspartate aminotransferase increased, Asthenia, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bicarbonate decreased, Blood bilirubin normal, Blood chloride normal, Blood creatine phosphokinase increased, Blood creatinine normal, Blood culture negative, Blood potassium decreased, Blood sodium normal, Blood urea normal, C-reactive protein increased, CSF culture negative, CSF lymphocyte count increased, CSF red blood cell count positive, Clonus, Clostridium test negative, Complement factor C3, Complement factor C4 increased, Computerised tomogram abdomen, Computerised tomogram head abnormal, Computerised tomogram spine, Computerised tomogram thorax, Computerised tomogram thorax normal, Culture stool negative, Culture urine negative, Cytology normal, Electroencephalogram abnormal, Extensor plantar response, Fatigue, Haemoglobin normal, Hyperacusis, Hyperreflexia, Immunoglobulin therapy, Mobility decreased, Muscular weakness, Myalgia, Neurological examination abnormal, Platelet count decreased, Pyrexia, Red blood cell sedimentation rate increased, Reflexes abnormal, Respiratory viral panel, SARS-CoV-2 test negative, Stiff person syndrome, Thrombocytopenia, Transaminases increased, Tremor, White blood cell count normal
SMQs:, Rhabdomyolysis/myopathy (broad), Liver related investigations, signs and symptoms (narrow), Haematopoietic thrombocytopenia (narrow), Lactic acidosis (broad), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hearing impairment (narrow), Generalised convulsive seizures following immunisation (broad), Chronic kidney disease (broad), Malignant lymphomas (broad), Noninfectious diarrhoea (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Hypoglycaemia (broad), Hypokalaemia (narrow), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Vitamin C 500mg, Vitamin D 1000IU, Mybetriq 25mg, zinc
Current Illness: none
Preexisting Conditions: overactive bladder
Allergies: Nitrofurantoin
Diagnostic Lab Data: WBC 6.5, Hgb 12.4, Plt 135 ESR 44 CRP 126 Na 136, K 3.4, Cl 105, bicarb 21, BUN 13, Cr 0.76 AST 107, ALT 105, Alk Phos 71, total bilirubin 07, albumin 3.2 CSF: 44 RBC, 6 nucleated cells, 83% lymphocytes CSF culture: no growth CSF cytology negative Blood cultures no growth to date Urine culture 10-50,000 colonies mixed flora CK 432 C3 163, C4 46 Stool pathogen panel negative C. diff negative Respiratory viral panel negative, including COVID 19 CT Cspine: 1.No acute fracture or malalignment. 2.Moderate multilevel degenerative change. Head CT: 1. No acute intracranial abnormalities are demonstrated. 2. Mild white matter disease, likely ischemic and due to mild microvascular disease. 3. Evidence of prior endovascular coiling of the left transverse and sigmoid sinuses. 4. Incidentally noted is presence of a possible arachnoid cyst over the left mid cerebellar hemisphere. Negligible mass effect. CT chest/abdomen/pelvis: no acute abnormality EEG: diffuse slowing
CDC Split Type:

Write-up: 79 yo female with past medical history only significant for endovascular coiling of cerebral aneurysms over 30 years ago presenting with fevers, fatigue, weakness, noise sensitivity, myalgias,and tremors. She exercises regularly and has become so weak that she cannot climb stairs. Neurological exam revealed hyperreflexia, subtle proximal muscle weakness, the presence of a startle reflex and rooting reflex, clonus, and a positive Babinski. Infectious work up has been negative, autoimmune evaluation is underway. Inpatient neurology consultation has been obtained, she was given a trial of diazepam for stiff person syndrome and started on daily IVIG on 2/3/2021 for a 5 day course. She continues to have an elevated CRP, a mild transaminitis, and mild thrombocytopenia. The ESR dropped from 44 to 20 with hydration. She has had no cognitive changes. No headache, visual changes, jaw pain. We are unable to obtain MRI given the presence of these coils which are not MRI compatible. Encephalitis immune antibodies are pending, myositis panel, MOG antibodies ADEM are pending, GAD65 antibody pending.


VAERS ID: 1004302 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-01-18
Onset:2021-01-19
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0140 / 2 LA / OT

Administered by: Private       Purchased by: ?
Symptoms: Immune thrombocytopenia, Petechiae, Platelet count decreased, SARS-CoV-2 test negative
SMQs:, Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: CALCIUM; SYNTHROID; TRAZODONE; VIT E [TOCOPHEROL]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypothyroidism
Allergies:
Diagnostic Lab Data: Test Date: 20210120; Test Name: platelet count; Result Unstructured Data: Test Result:8,000; Comments: ITP with baseline platelet count of 60,000; Test Date: 20210120; Test Name: Nasal Swab; Test Result: Negative
CDC Split Type: USPFIZER INC2021057558

Write-up: admitted to hospital with platelet count of 8,000; petechiae; This is a spontaneous report from a contactable physician. A 60-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL0140) via Intramuscular on 18Jan2021 into left arm at a single dose for covid-19 immunization. Medical history included hypothyroidism and neomycin allergies. The patient did not get covid prior vaccination. Concomitant medications included calcium, levothyroxine sodium (SYNTHROID), trazodone, tocopherol (VIT E) and no other vaccine in four weeks. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL9261) via Intramuscular on 28Dec2020 into left arm at a single dose for covid-19 immunization. 24 hours after injection she developed petechiae and was admitted to hospital with platelet count of 8,000 on 20Jan2021 22:00, the patient has ITP with baseline platelet count of 60,000. All events lead to hospitalization for 5 days (PENDING CLARIFICATION) and received IgG and oral Dexamethas as treatment. On 20Jan2021, the patient did Sars Co V 2 RNA test via Nasal Swab and result negative. The outcome of the events was recovering.; Sender''s Comments: Based on a close chronological association, a causal relationship between events petechiae and thrombocytopenia and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) cannot be excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 1004620 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Female  
Location: Indiana  
Vaccinated:2021-01-21
Onset:2021-01-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Fatigue, Headache, Immune thrombocytopenia, Immunoglobulin therapy, Injection site rash, Injection site reaction, Oral mucosal eruption, Petechiae, Platelet count decreased, Platelet transfusion
SMQs:, Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ALBUTEROL [SALBUTAMOL]; TRULICITY; LEXAPRO; GLIMEPIRIDE; HYDROCHLOROTHIAZIDE; BASAGLAR; LISINOPRIL; LORAZEPAM; METFORMIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthritis; Diabetes; Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 20210125; Test Name: platelet count; Result Unstructured Data: Test Result:2,000; Test Date: 20210125; Test Name: platelet count; Result Unstructured Data: Test Result:1,000
CDC Split Type: USPFIZER INC2021092239

Write-up: petechial rash around injection site and mouth; found to have platelet count of 2,000.; patient had ITP; extreme headaches; fatigue; This is a spontaneous report from a contactable pharmacist. A 55-year-old non-pregnant female patient of received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular on 21Jan2021 as first single dose for covid-19 immunization. Medical history included hypertension, diabetes, arthritis from unknown dates. Concomitant medication within two weeks included albuterol (salbutamol), dulaglutide (TRULICITY), escitalopram oxalate (LEXAPRO), glimepiride (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), insulin glargine (BASAGLAR), lisinopril (MANUFACTURER UNKNOWN), lorazepam (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN). The patient previously took ibuprofen (MOTRIN) and experienced allergies and drug intolerance. The patient experienced serious events, that involved hospitalization and were life threatening illness (immediate risk of death from the event) as follows: The patient experienced extreme headaches on 21Jan2021 with outcome of recovering; fatigue on 21Jan2021 with outcome of recovering; petechial rash around injection site and mouth on 25Jan2021 with outcome of recovering; patient had immune thrombocytopenia (ITP) on 21Jan2021 with outcome of recovering; found to have platelet count of 2,000 on 25Jan2021 with outcome of recovering. The patient was hospitalized for extreme headaches, fatigue, petechial rash around injection site and mouth, patient had ITP and found to have platelet count of 2,000 for five days. The events were also serious as they were considered life-threatening. The patient underwent lab tests and procedures which included platelet count 2,000 on 25Jan2021; platelet count 1,000 on 25Jan2021. Details were as follows: following the vaccine , which had been 21Jan2021 and had extreme headaches and fatigue for the next two days. On 25Jan2021, the patient developed petechial rash around injection site and mouth. Patient was seen at OSH emergency department and found to have platelet count of 2,000. Patient transferred to the reports facility on 25Jan2021 for hematology consult, and was found to have platelets of 1,000. Extensive hematology workup was completed and it was determined patient had ITP. Therapeutic measures were taken as a result of extreme headaches, fatigue, petechial rash around injection site and mouth (petechiae), patient had ITP and found to have platelet count of 2,000. Therapeutic measures included platelet transfusion, dexamethasone 40mg daily, 3 doses of IVIG. The patient was recovering from the events as aforementioned. The patient has not been COVID tested post vaccination. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event due to temporal association. However patient underlying medical conditions cannot be ruled out as contributing to the reported events


VAERS ID: 1004700 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Male  
Location: Virginia  
Vaccinated:2020-12-20
Onset:2021-01-04
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Angiogram, Blood culture negative, Chest X-ray normal, Deep vein thrombosis, Dyspnoea, Dyspnoea exertional, Electrocardiogram, Electrocardiogram ST segment abnormal, Fatigue, Hypoxia, Iron deficiency anaemia, Occupational exposure to SARS-CoV-2, Pain in extremity, Phlebitis, Pulmonary embolism, Pyrexia, SARS-CoV-2 test negative, Thrombophlebitis, Ultrasound Doppler abnormal, White blood cell count increased
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Respiratory failure (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Iron 325 mg once daily
Current Illness: None
Preexisting Conditions: Remote history colon cancer in 2011, treated with surgery and chemotherapy, in remission; remote hx dvt and PE 2013 possibly provoked by long car ride and b-12 deficiency; iron deficiency anemia to 10.2 gm 10/2020 with no identifiable blood loss, likely malabsorbtion relatgtd to terminal ileum resection
Allergies: None
Diagnostic Lab Data: CXR negative, EKG NSST changes WBC minimally elevated Blood cultures negative Iron deficiency anemia noted in October (which was originally thought to be source of dsypnea) had resolved at time of first ER eval 1/31/21 A total of 4 negative COVID tests, two rapid antigen, two pcr LE Doppler as above; PE dx clinical based on dyspnea, hypoxia; CT angio deferred as not affecting management Dx of thrombophlebitis is firm; association with covid vaccine is speculative Initial onset of dyspnea was within 10 days of first COVID vaccine, definite phlebitis and hypoxia with 10 days of second covid vaccine.
CDC Split Type:

Write-up: DVT and probable pulmonary embolus based on hypoxia Patient is physician who cares for patients in NH and ALF where there is documented COVID First dose COVID vaccine 12/20/20, second dose 1/10/20 Some shortness of breath developed about 1/10, not severe 1/30 Leg pain, fever to 101.6 abrupt onset extreme fatigue, ER eval 1.31 negative eval including neg rapid and PCR COVID tests Persistent sx led to repeat ER eval including LE dopper confirming occlusive femoral vein thromboxis; no hypoxia at rest but desat to 85% on exertion (climbing one flight of steps) Started anticoagulants 2/4/21 on home treatment; not working since 1/30/21


VAERS ID: 1004777 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Male  
Location: Tennessee  
Vaccinated:2021-01-18
Onset:2021-01-19
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3246 / 2 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Computerised tomogram head, Computerised tomogram thorax, Fibrin D dimer increased, Headache, Pulmonary oedema, Thrombosis
SMQs:, Cardiac failure (narrow), Haemorrhage laboratory terms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: One a day men?s 50 plus multivitamin, Ashwaganda, saw palmetto, milk thistle, grape seed extract, garlic extract, gingko biloba, melatonin.
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: CT scan of lungs and brain, blood tests that revealed potentially blood clots (d-dimer level was high).
CDC Split Type:

Write-up: Headache the next morning after receiving vaccine that hasn?t gone away, fluid in left lung, blood clots in right lung and leg.


VAERS ID: 1005993 (history)  
Form: Version 2.0  
Age: 73.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-01-08
Onset:2021-01-18
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 - / -

Administered by: Private       Purchased by: ?
Symptoms: Condition aggravated, Full blood count, Immune thrombocytopenia, Platelet count abnormal, Platelet count decreased, Platelet count increased, SARS-CoV-2 test negative
SMQs:, Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: AMLODIPINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Idiopathic thrombocytopenic purpura (ITP for 5 years now/ IPP); Platelets decreased (4 years ago to the point she was Hospitalized for 10 days and her platelets were almost count zero)
Allergies:
Diagnostic Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:High; Test Name: platelets/ CBC; Result Unstructured Data: Test Result:244,000; Test Name: platelets/ CBC; Result Unstructured Data: Test Result:almost count zero; Test Date: 20210118; Test Name: platelets/ CBC; Result Unstructured Data: Test Result:94,000; Test Date: 20210120; Test Name: platelets/ CBC; Result Unstructured Data: Test Result:248,000; Test Date: 20210118; Test Name: Rapid Covid test; Test Result: Negative
CDC Split Type: USPFIZER INC2021058558

Write-up: platelets dropped from 244,000 to 94,000/idiopathic thrombocytopenic purpura (ITP) for 5 years; platelets dropped from 244,000 to 94,000/idiopathic thrombocytopenic purpura (ITP) for 5 years; This is a spontaneous report from a contactable consumer (patient''s spouse). A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1284 and expiry date: unknown), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. Medical history included high blood pressure and idiopathic thrombocytopenic purpura (ITP) for 5 years at a very severe level 4 years ago to the point she was hospitalized for 10 days and her platelets were almost count zero. Concomitant medication included amlodipine. It was reported that despite patient''s condition, she has received multiple vaccines, mostly flu in the last 4 years, and had no problems. 11 days after the 1st dose, patient''s platelets dropped from 244,000 to 94,000 on 18Jan2021. Patient consulted the hematologist and was prescribed with 20 mg of Prednisone. Then, after 14 days, his wife''s platelets rose back up to 248,000 on 20Jan2021. Patient was scheduled to receive the 2nd dose of the vaccine a week from the time of report. Reporter to know if patient should still get the 2nd dose, and if there have been studies for people with ITP and the use of the vaccine. Patient had a rapid Covid test on Monday (18Jan2021) that came back negative and antibodies test on Monday afternoon. Outcome of the event was recovered.


VAERS ID: 1006364 (history)  
Form: Version 2.0  
Age: 78.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-01-31
Onset:2021-02-03
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-02-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9263 / 1 AR / IM

Administered by: Other       Purchased by: ?
Symptoms: Contusion, Petechiae, Rash pruritic
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Accidents and injuries (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: phenazopyridine, flomax, alprazolam, losartan
Current Illness: none
Preexisting Conditions: hx of prostate cancer, vitamin d deficiency, hx of colon cancer, hx of renal cell cancer, atherosclerosis of aorta, DDD, diabetes type 2, hx of hemicolectomy, hypertensive renal disease
Allergies: sulfa drugs, cipro
Diagnostic Lab Data:
CDC Split Type:

Write-up: pruritic rash on left forearm, right calf, right medial aspect of lower leg bruising/petechiae


Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=18&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=PFIZER/BIONTECH

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166